Efficient Market Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Efficient Market Advisors’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,200	Closed	-$39K	–	141
2015 Q1	$39K	Hold	1,200	–	–	0.01%	84
2014 Q4	$38K	Hold	1,200	–	–	0.01%	87
2014 Q3	$30K	Hold	1,200	–	–	0.01%	81
2014 Q2	$27K	Buy	1,200 +200	+20%	+$4.18K	0.01%	82
2014 Q1	$24K	Hold	1,000	–	–	0.01%	86
2013 Q4	$25K	Sell	1,000 -500	-33%	-$11.8K	0.01%	79
2013 Q3	$41K	Hold	1,500	–	–	0.01%	72
2013 Q2	$27K	Buy	+1,500	New	+$20.7K	0.01%	72

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Efficient Market Advisors's ACAD Position: Q2 2015 in Review

Efficient Market Advisors sold out of Acadia Pharmaceuticals (ACAD) in Q2 2015, closing a stake of 1,200 shares — an estimated $39K sold.

Efficient Market Advisors first reported a position in ACAD in Q2 2013 and held it in 8 quarters. The position peaked at $41K in Q3 2013. 188 funds tracked by Wall St. Rank hold ACAD as of Q2 2015.

Efficient Market Advisors reported no remaining Acadia Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
Efficient Market Advisors sold 1,200 Acadia Pharmaceuticals shares in Q2 2015, an estimated $39K.
Efficient Market Advisors first reported a position in Acadia Pharmaceuticals in Q2 2013 and held it in 8 quarters.
Efficient Market Advisors's Acadia Pharmaceuticals position peaked at $41K in Q3 2013.
188 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2015.

Based on Efficient Market Advisors's 13F filing for Q2 2015, filed 13 Jul 2015.